Quick Overview

NOT AVAILABLE IN THE U.S.A.

The Welch Allyn RETeval-DR Electroretinograph is designed for healthcare providers who want to improve management of their patients with diabetes. In just three minutes, you can objectively screen for vision-threatening diabetic retinopathy (VTDR) wherever patients receive care. Welch Allyn RETeval-DR Electroretinograph enables efficient, comfortable, non-mydriatic screening for VTDR that improves patient compliance to help preserve vision in your patients with diabetes.

NOT AVAILABLE IN THE U.S.A.

In just three minutes, you can objectively screen for vision-threatening diabetic retinopathy (VTDR) wherever patients receive care with comfortable, non-mydriatic RETeval-DR Electroretinograph.